Wegovy Medicaid Coverage by State Tier (2026 Guide)
A state-by-state breakdown of Wegovy (semaglutide 2.4 mg) Medicaid coverage tiers, prior-authorization rules, and every legitimate way to lower your out-of-pocket cost in 2026.
Vaginal Estradiol Compassionate Use and Expanded Access: How to Get It Cheaper
A guide to compassionate use, expanded access, manufacturer assistance programs, HSA/FSA eligibility, and discount strategies for vaginal estradiol in 2026.
Vaginal Estradiol International Purchase Legalities: What You Need to Know Before You Buy
A guide to the legal, regulatory, and cost field for purchasing vaginal estradiol internationally, including FDA rules, cross-border import policies, HSA/FSA eligibility, and legitimate discount pathways.
Viagra Medicare Part D Coverage: What's Covered, What Isn't, and How to Pay Less in 2026
Medicare Part D generally excludes Viagra (sildenafil) for erectile dysfunction, but loopholes, alternatives, and savings programs can cut your cost to $10, $50/month. Here is exactly what to do.
Vyvanse Manufacturer Bridge Programs: How to Get Lisdexamfetamine Cheaper in 2026
A complete guide to Takeda's Vyvanse manufacturer bridge and savings programs, generic lisdexamfetamine options, and every legitimate route to reduce your out-of-pocket cost in 2026.
Vyvanse Medicare Part D Coverage: What to Expect in 2026
A complete guide to Vyvanse (lisdexamfetamine) Medicare Part D coverage in 2026, including formulary tiers, cost-reduction strategies, generic alternatives, and manufacturer savings programs.
Zepbound HSA/FSA Eligibility and Submission: Complete 2026 Guide
Learn whether Zepbound (tirzepatide) qualifies for HSA and FSA reimbursement, how to submit claims, what documentation your plan needs, and proven strategies to lower your out-of-pocket cost in 2026.
Zepbound International Purchase Legalities: What You Need to Know in 2026
A guide to the legal, regulatory, and financial realities of purchasing Zepbound (tirzepatide) outside the United States, including customs rules, FDA import policy, and legitimate cost-saving alternatives.
Zepbound Medicare Part D Coverage: What to Expect in 2026
Does Medicare Part D cover Zepbound (tirzepatide) for weight loss? Learn the current coverage rules, how to lower your out-of-pocket cost, and what alternatives exist if your plan denies the claim.
Cardiovascular Prevention: 2026 Doctor's Guide
A comprehensive, evidence-graded guide to cardiovascular prevention in 2026: when to treat, which medications work, how to compare options, and who should avoid each therapy. Written by the HealthRX.com medical team and reviewed by board-certified physicians.
Therapeutic Peptides: Complete 2026 Guide
A guide to therapeutic peptides in 2026: what they are, how they work, which uses have FDA approval and randomized-trial support versus animal or early-phase data only, safety concerns, and what to ask before starting one.
Weight Loss Medication 2026: Which Drug Works Best
Compare FDA-approved weight loss medications by results: tirzepatide up to 22.5%, semaglutide 14.9%. See BMI eligibility and how to choose with your doctor.
Cost of NMN Supplements in 2026: Prices, Compounded Rapamycin, and Insurance Reality
A detailed 2026 pricing guide for NMN supplements, compounded rapamycin, and other longevity-focused compounds, plus an honest look at what insurance will and will not cover for off-label use.
The 'Research Use Only' Myth: What FDA Status Actually Means for BPC-157, TB-500, and Compounded Peptides in 2026
BPC-157 and TB-500 are not 'research use only' chemicals. This guide explains their actual FDA regulatory status, what 503A compounding law permits, how to read a peptide CoA, and what changed after the 2024 FDA bulk drug substance rulings.
Spironolactone HSA/FSA Eligibility and Submission: How to Save on Your Prescription in 2026
Learn whether spironolactone qualifies for HSA and FSA reimbursement, how to submit claims correctly, and every other strategy to reduce your out-of-pocket cost in 2026.
Ipamorelin Regulatory Status: US, EU, Canada, and UK (2025)
A breakdown of ipamorelin acetate's legal and regulatory standing in the United States, European Union, Canada, and United Kingdom, including FDA compounding rules, WADA classification, and prescribing pathways.
Oral Minoxidil International Purchase Legalities: What You Need to Know Before You Buy
A guide to the legal status of oral minoxidil across borders, how customs and import rules apply, and legitimate ways to lower your cost through telehealth, compounding pharmacies, and HSA/FSA benefits.
Leqvio (Inclisiran) Long-Term Cardiovascular Benefits
LDL-C stays down about 50% at 17 months in ORION-10/11, but proof it cuts heart attacks and strokes awaits ORION-4 results through 2026.
Pituitary Coronal MRI: What the Scan Shows and Why It's Ordered
Pituitary coronal MRI is ordered after prolactin over 100 ng/mL or confirmed hypercortisolism; a 3mm gadolinium sella scan detects lesions under 10mm.
ED After Prostatectomy: Causes, Recovery Timeline, and Treatment Options
Erectile dysfunction after prostatectomy affects up to 85% of men. Learn why it happens, how long recovery takes, and which treatments, from PDE5 inhibitors to penile rehabilitation, have the strongest evidence.
MK-677 (Ibutamoren) in Special Populations: Transplant, HIV, and Beyond
MD-level review of MK-677 (ibutamoren) pharmacology and clinical evidence in transplant recipients, people living with HIV, older adults, and other special populations. Includes mechanisms, dosing, risks, and primary-source citations.
Provigil Non-Responder Profile: Who Does Modafinil Not Work For?
A clinical and patient-reported breakdown of who fails to respond to Provigil (modafinil), why it happens, and what options exist. Backed by trial data, pharmacogenomics, and synthesized real-world reviews.
Sedation on Oral Micronized Progesterone: Week-by-Week Timeline of What to Expect
Prometrium may cause transient dizziness and drowsiness. See the label wording, dizziness rates in the trials, and how single-dose timing works.
Egrifta (Tesamorelin) Mechanism of Action: Full Pathway Explained
A full MD-level breakdown of how tesamorelin (Egrifta) works, from GHRH receptor binding and pulsatile GH release to IGF-1 signaling, lipolysis, and visceral fat reduction in HIV-associated lipodystrophy.
Spironolactone Re-Titration After Stopping: Dosing Guide for Acne
How to safely re-titrate spironolactone for acne after a treatment break, including starting doses, escalation schedules, what to monitor, and when to call your prescriber.
Trulicity HSA/FSA Eligibility and Submission: A Complete 2026 Guide
Can you use an HSA or FSA to pay for Trulicity (dulaglutide)? Yes. Learn the IRS rules, step-by-step submission process, savings stacks, and 2026 program updates from HealthRX.com.
Low-Dose Naltrexone Employer and ICHRA Coverage Navigation
A clinical guide to getting low-dose naltrexone (LDN) covered through employer health plans, ICHRA accounts, HSA/FSA funds, and discount programs in 2026.
Rybelsus International Purchase Legalities: What You Need to Know Before You Buy
A guide to the legal, safety, and cost considerations for purchasing Rybelsus (oral semaglutide) internationally, including FDA rules, Canadian pharmacy options, and legitimate discount programs.
Tretinoin HSA/FSA Eligibility and Submission: How to Pay Less in 2026
Can you use your HSA or FSA for tretinoin? Complete 2026 guide covering prescription vs. OTC rules, how to submit a claim, and every other way to reduce your tretinoin cost.
Adderall XR and Autoimmune Disease: What Clinicians and Patients Need to Know
A clinician-grade review of Adderall XR (mixed amphetamine salts) use in patients with autoimmune conditions, covering immune modulation, drug interactions, cardiovascular risk, and practical prescribing guidance.
Is Adderall Bad for Your Liver? What the Data Shows
Liver injury is not a listed adverse reaction on the Adderall tablet label. See how amphetamine is metabolized and which drugs change its levels.
Adderall XR Older Adult (50 to 64) Dosing: What Patients and Prescribers Need to Know
A clinical guide to Adderall XR (mixed amphetamine salts) dosing for adults aged 50, 64, covering starting doses, titration schedules, cardiovascular screening, drug interactions, and hormonal considerations unique to this age group.
Adderall XR Rebound Effects When Stopping: What Clinicians and Patients Need to Know
A guide to Adderall XR (mixed amphetamine salts) rebound and discontinuation effects, including mechanism, timeline, symptom management, and tapering protocols.
Adderall XR Storage, Stability & Shelf Life
How to store Adderall XR (mixed amphetamine salts) correctly, what happens when it degrades, and exactly how long it stays potent, with FDA-cited evidence and clinical pharmacist guidance.
Is Adderall Nephrotoxic? What the Evidence Shows
Adderall XR isn't directly nephrotoxic at therapeutic doses, but hypertension, rhabdomyolysis, and vasoconstriction can indirectly harm kidneys if unmonitored.
Adrenal Adenoma - Causes, Workup, and Treatment
Most adrenal adenomas are benign and non-functioning, found incidentally on CT. Learn the hormone workup that decides surveillance vs treatment.
Prednisone Under 2 Weeks: Is a Taper Needed?
Courses under 2 weeks rarely suppress the HPA axis; risk rises after 3+ weeks or doses above 20 mg prednisone/day. See thresholds and taper guidance.
AOD-9604 Geriatric (65+) Caregiver Administration Guidance
A guide for caregivers administering AOD-9604 (HGH fragment 176-191) to adults aged 65 and older, covering dosing, injection technique, safety monitoring, and age-specific considerations.
Vyleesi Geriatric (65+) Caregiver Administration Guidance
A complete clinical guide to administering bremelanotide (Vyleesi) in patients aged 65 and older, covering pharmacokinetics, dose timing, caregiver injection technique, contraindications, and monitoring protocols prepared by the HealthRX.com Editorial Team.
Vyleesi (Bremelanotide) in Adults 65 and Older: What Geriatric Patients and Their Clinicians Need to Know
A guide to bremelanotide (Vyleesi) use in patients 65 and older, covering pharmacokinetics, safety signals, dose adjustments, cardiovascular precautions, and transition-of-care planning for geriatric patients with hypoactive sexual desire disorder.
Cialis (Tadalafil) for Adults 65 and Older: Caregiver Administration Guidance
A guide for caregivers helping older adults take tadalafil (Cialis) safely, covering dosing, drug interactions, fall risk, and when to call the prescriber.
Cialis (Tadalafil) in Adults 65 and Older: What Geriatric Patients and Their Caregivers Need to Know
A guide to tadalafil use in adults aged 65 and older, covering dosing adjustments, drug interactions, cardiovascular safety, BPH management, and the transition from pediatric or adult urology care into geriatric-appropriate protocols.
Enclomiphene Citrate for Men 65 and Older: Transitioning to Adult Care
A guide to enclomiphene citrate use in geriatric men (65+), covering pharmacology, dosing, monitoring, safety, and how to transition patients from pediatric or general adult care into age-appropriate testosterone management protocols.
Epitalon for Adults 65 and Older: What Geriatric Patients Need to Know About Transitioning to This Peptide
What is known about epitalon in adults 65 and older, including the limited human studies, safety data gaps, and its regulatory and compounding status.
Oral Estradiol for Women 65+: School, Work, and Activity Considerations
A guide to oral estradiol use in women aged 65 and older, covering cognitive function, physical activity, fall risk, driving, and continuing education, with primary-source citations throughout.
Oral Estradiol in Geriatric Patients (65+): Transition to Adult Care
A clinical guide to oral estradiol dosing, safety monitoring, and care transitions for patients aged 65 and older, reviewed by board-certified physicians.
Estradiol Patch Geriatric (65+): School and Activity Considerations
A guide for adults 65+ using estradiol transdermal patches: how patch use affects physical activity, cognitive engagement, fall risk, and daily routines, with dosing, safety data, and practical clinical guidance.
GHK-Cu for Adults 65 and Older: What Geriatric Patients Need to Know About Transitioning to Care
A guide to GHK-Cu (copper tripeptide) use in adults 65 and older, covering pharmacology, safety considerations, dosing context, and how older patients transition into supervised peptide therapy.
Low-Dose Naltrexone for Older Adults (65+): Caregiver Administration Guidance
A clinical guide for caregivers managing low-dose naltrexone (LDN) in adults aged 65 and older, covering dosing caution, timing, storage, side-effect monitoring, and when to call the prescriber.
Low-Dose Naltrexone for Adults 65+: School, Work, and Activity Considerations
A clinical guide to low-dose naltrexone (LDN) use in geriatric patients, covering cognitive effects, physical activity, driving safety, fatigue management, and daily-life considerations for adults aged 65 and older.
Low-Dose Naltrexone for Older Adults (65+): Transitioning to Geriatric Care
A clinical guide to low-dose naltrexone (LDN) use in adults 65 and older, covering dose adjustments, drug interactions, renal and hepatic considerations, and how to manage the transition from adult to geriatric care protocols.
MK-677 (Ibutamoren) in Adults 65 and Older: School, Activity, and Lifestyle Considerations
A clinical guide to MK-677 (ibutamoren) use in geriatric patients, covering physical activity compatibility, cognitive engagement, fall risk, dosing, and safety data from named trials.
MOTS-c Geriatric (65+): School and Activity Considerations
A guide to MOTS-c use in adults 65 and older, covering physical activity integration, cognitive engagement, dosing context, safety signals, and evidence from human and animal trials.
Mounjaro (Tirzepatide) for Adolescents Age 12 to 17: Off-Label Use, Evidence, and Clinical Considerations
A guide to off-label tirzepatide (Mounjaro) use in adolescents aged 12 to 17, covering the current evidence base, dosing considerations, approved alternatives, and what families should ask before starting treatment.
NMN and NR for Adults 65+: Caregiver Administration Guidance
A guide for caregivers managing NMN or NR supplementation in adults aged 65 and older, covering dosing, timing, drug interactions, monitoring, and when to pause.
NMN and NR for Adults 65+: What Geriatric Patients Need to Know Before Starting NAD+ Precursors
NMN and NR after age 65: human trial results, doses studied, medication reviews, symptom tracking, and practical questions for choosing a supplement.
Oral Micronized Progesterone in Geriatric Patients (65+): Transition to Adult Care
A clinical guide to oral micronized progesterone (Prometrium) for patients 65 and older transitioning to adult care, covering dosing, safety, fall risk, and monitoring.
Ozempic for Adults 65 and Older: Complete Caregiver Administration Guidance
Step-by-step caregiver guidance for administering Ozempic (semaglutide) to adults 65 and older, including injection technique, hypoglycemia risk, dose titration, and storage tips backed by FDA labeling and geriatric clinical evidence.
Prometrium Geriatric (65+) Caregiver Administration Guidance
A guide for caregivers managing Prometrium (micronized progesterone) in adults aged 65 and older, covering dosing, fall risk, cognitive considerations, and practical administration tips.
PT-141 (Bremelanotide) for Adults 65 and Older: School, Activity, and Daily Life Considerations
What PT-141 research shows for adults 65 and older, including trial ages, blood-pressure timing, naltrexone interactions, and daily activities.